These results, along with a past report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 support the concept of focusing on ACKR3 as a unique strategy to modulate the opioid technique, which could open up new therapeutic avenues for opioid-associat